Nanomedic Technologies Ltd. is an Israeli bio-medical therapeutics high-technology company specializing in clinical research, and distribution of medical devices based on electrospinning technology. It is focused on the development of Electrospun Healing Fibers (EHF™) with its ultimate goal being embedded cells for tissue regeneration. This is the future of advanced wound care solutions that will fill the void of personalized medicine while endeavoring to cure and heal patients rather than ameliorating symptoms.
We have already started marketing and sales of its wound healing Spincare system to selected global healthcare institutions, with a market potential of over $18B. Nanomedic’s Spincare patented platform technology, together with its disposable ampule, has wide market applications both within and outside the hospital environs. It is CE marked and FDA clearance is expected in mid-2021.
Leveraging electrospinning technology, Nanomedic has developed the world’s first commercialized handheld device that enables healthcare professionals to print – in real-time – a nanofibrous healing matrix directly onto a patient’s wound. The Spincare wound healing System is a total paradigm shift in the treatment of wounds from superficial to hard-to-heal chronic and complex wounds.
Nanomedic is committed to advancing the standard of care and helping improve wound healing across the healthcare continuum.